|
Harten Group in the news |
||
|
This section includes 'reprints' of recently published articles and documents featuring Harten Group. (You will need a PDF viewer such as Adobe Acrobat installed to view some these documents; you can download a copy free of charge at www.adobe.com if you do not already have one). Rapid Access to Specialist SkillsTim Ewbank discusses 'The Hows and Whys of Interim Management' in this article, published in CR Focus, October 2008 Working in vaccines, a primerConsidering a career in vaccines? Novartis Vaccines & Diagnostics medical director provides a run-down of the top issues in this exciting field. Text of article published in Pharmafocus, October 2008. Competency-based interviewing: Selling your skillsetDrawing on previous triumphs and failures can help an interview panel determine whether you are up to the job. This article explores how best to prepare. Text of article published in Pharmafocus, September 2008. GCP: It's never too early to startVernon Harten-Ash and Val Lyness offer Biotech start-ups tips to achieving trial success in addition to maintaining GCP compliance. Text of article published in GCPj, June 2008. Pharma stands still while Biotech gathers pace (PDF)Harten Group's sixth Annual Industry Survey canvassed views from over 600 senior executives in pharma and biotech companies. The results were published in CR Focus, April 2008. Should I stay or should I go? (PDF)There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job. Article published in Pharmafocus, April 2008 Could Working As An Interim Improve Your Work/life Balance? (PDF)Lesley Crosland explores the 'work-life balance' issue in an article published in Pharmaceutical Physician, September 2007 How to make friends and influence people (PDF)Mentoring can unlock the door to career success and advancement - article published in Phamafocus, September 2007 Finding top people for the top job (PDF)Filling senior roles need not be a daunting task, says Dr Vernon Harten-Ash, in this article published in Pharmafocus, September 2007
|